News
OPK
1.470
-2.00%
-0.030
Phillip Frost Is The Chairman & CEO of OPKO Health, Inc. (NASDAQ:OPK) And Just Spent US$319k On Shares
Potential OPKO Health, Inc. ( NASDAQ:OPK ) shareholders may wish to note that the Chairman & CEO, Phillip Frost...
Simply Wall St. · 11/16 10:08
OPKO Health, electroCore And This Penny Stock Insiders Are Aggressively Buying
Benzinga · 11/11 14:18
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
OPKO Health's (OPK) third-quarter results reflect dismal segmental performances.
Zacks · 11/09 13:39
BRIEF-Opko Health Inc Reports Quarterly Loss Per Share Of $0.11
Reuters · 11/08 23:05
OPKO Health (OPK) Reports Q3 Loss, Tops Revenue Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of -10% and 4.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/08 22:35
OPKO Health down 5% following Q3 top and bottom line misses
Seekingalpha · 11/08 21:47
OPKO Health Q3 EPS $(0.11) Misses $(0.08) Estimate, Sales $179.70M Miss $183.51M Estimate
Benzinga · 11/08 21:24
OPKO Health GAAP EPS of -$0.11 misses by $0.03, revenue of $179.7M misses by $3.81M
Seekingalpha · 11/08 21:16
-- Earnings Flash (OPK) OPKO HEALTH Reports Q3 Revenue $179.7M, vs. Street Est of $183.5M
-- Earnings Flash (OPK) OPKO HEALTH Reports Q3 Revenue $179.7M, vs. Street Est of $183.5M
MT Newswires · 11/08 16:26
Earnings Outlook For OPKO Health
Benzinga · 11/07 18:20
NBA-Nike suspends ties with Kyrie Irving, cancels next shoe release
Reuters · 11/05 01:59
OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022
MIAMI, Nov. 01, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2022 after the close of the U.S. financial markets on Tuesday, November 8, 2022. OPKO...
GlobeNewswire · 11/01 12:00
OPKO Health, Inc. (NASDAQ:OPK) insiders have had a fantastic week as stock increased 5.1%, and they haven't stopped buying
A look at the shareholders of OPKO Health, Inc. ( NASDAQ:OPK ) can tell us which group is most powerful. The group...
Simply Wall St. · 10/30 12:04
OPKO Health And 2 Other Penny Stocks Are Aggressively Buying
Benzinga · 10/21 18:16
$6 Million Bet On This This Stock? Check Out These 3 Penny Stocks Insiders Are Buying
Gold futures traded slightly lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 10/18 13:47
OPKO Health, Inc. (NASDAQ:OPK) insiders placed bullish bets worth US$13m in the last 12 months
Quite a few insiders have dramatically grown their holdings in OPKO Health, Inc. ( NASDAQ:OPK ) over the past 12...
Simply Wall St. · 10/03 11:17
Here's Why You Should Hold on to OPKO Health (OPK) Stock Now
Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.
Zacks · 09/26 14:38
Eton Pharmaceuticals, GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Nasdaq Composite dropped by around 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 09/26 12:48
Investors five-year losses grow to 65% as the stock sheds US$139m this past week
We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. For...
Simply Wall St. · 09/05 16:28
3 Reasons to Hold OPKO Health (OPK) Stock in Your Portfolio
Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee.
Zacks · 08/23 14:30
More
Webull provides a variety of real-time OPK stock news. You can receive the latest news about Opko Health through multiple platforms. This information may help you make smarter investment decisions.
About OPK
OPKO Health, Inc. is a healthcare company. The Company’s segments include Diagnostics and Pharmaceutical. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP and hGH-CTP. It also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.